基于纳米的药物输送系统在肝细胞癌中
Maryam Sadat Abtahi1,2, Alireza Fotouhi1,3, Niloufar Rezaei1
1Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Journal of drug targeting
|June 7, 2024
概括
改善肝细胞癌 (HCC) 治疗需要更好的药物输送. 基于纳米技术的药物递送系统 (DDS) 提供有针对性的疗法,以提高HCC患者的疗效和减少副作用.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 肝细胞癌 (HCC) 呈现高复发率和不良预后,需要改进化疗.
- 目前的化疗方案往往缺乏向药物输送,导致严重的副作用和有限的疗效.
研究的目的:
- 对肝细胞癌 (HCC) 基于纳米技术的药物递送系统 (DDS) 的设计进行审查.
- 突出使用纳米基DDS用于HC治疗的创新临床研究.
主要方法:
- 关于纳米技术在癌症治疗中的应用的科学文献的综述.
- 分析不同的纳米粒子设计和DDS的表面工程策略.
- 从临床研究中对纳米基DDS用于HC的数据的汇编.
主要成果:
- 纳米技术为HCC的向药物输送提供了先进的解决方案.
- 各种纳米粒子DDS设计 (主动,被动,刺激响应) 显示了提高效能的潜力.
- 纳米颗粒的表面工程对于选择性向瘤部位递送药物至关重要.
结论:
- 基于纳米的DDS代表了HCC治疗策略的有希望的进步.
- 通过纳米技术进行有针对性的治疗可以显著改善治疗结果并减少副作用.
- 对纳米基DDS进行进一步的临床研究是广泛的HCC治疗的必要条件.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
113
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
113
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
115
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
115